Literature DB >> 17554054

Cardiovascular and cancer mortality after radioiodine treatment of hyperthyroidism.

Mark Vanderpump.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17554054     DOI： 10.1210/jc.2007-0837

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  4 in total

1.  Long-term risks in hyperthyroid patients treated with radioiodine: is there anything new?

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09       Impact factor: 9.236

Review 2.  Diagnosis and management of Graves disease: a global overview.

Authors:  Luigi Bartalena
Journal:  Nat Rev Endocrinol       Date:  2013-10-15       Impact factor: 43.330

3.  In contrast to matrix metalloproteinases, serum adiponectin concentrations increase after radioiodine treatment of thyrotoxicosis.

Authors:  A Lewiński; A Brona; Kc Lewandowski; E Skowrońska-Jóźwiak; A Milewicz
Journal:  Thyroid Res       Date:  2012-10-29

4.  Effects of radioiodine administration on serum concentrations of matrix metalloproteinases, adiponectin and thrombospondin-1.

Authors:  Andrzej Lewinski; Anna Brona; Krzysztof C Lewandowski; Diana Jedrzejuk; Anna Bohdanowicz-Pawlak; Elżbieta Skowronska-Jozwiak; Małgorzata Bienkiewicz; Andrzej Milewicz
Journal:  Thyroid Res       Date:  2013-08-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.